Clin2
NCT05212571Possibly a fitEnrolling by invitation

IV esketamine to improve long-term pain in CRPS

Complex Regional Pain SyndromesCRPS (Complex Regional Pain Syndromes)

Part of Brain & nervous system clinical trials.

This study looks at whether giving esketamine through a vein can help reduce long-term pain in people with complex regional pain syndrome (CRPS). You may be able to join if your CRPS diagnosis matches specific international criteria and you can safely take the study medicine.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have CRPS that fits the IASP “Budapest” diagnosis rules (or CRPS with some features in remission)
  • Your CRPS affects only one arm and/or only one leg
  • You’re able and willing to take part in study activities
  • You can understand Dutch well enough to participate
  • You are 18 years old or older

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06161805Recruiting· Phase 3
Esketamine for chronic pain from endometriosis

This trial tests if esketamine, a nasal spray, can reduce chronic pelvic pain in women with endometriosis that hasn't improved with standard painkillers. You may qualify if you have severe pain and are scheduled for endometriosis surgery.

Delft
NCT07230171Recruiting
Short-term S-ketamine for fibromyalgia pain relief

This trial tests if low-dose S-ketamine, given as a short intravenous infusion, can safely improve fibromyalgia pain and other symptoms for people who haven't gotten enough relief from non-drug treatments. S-ketamine is a fast-acting medicine that blocks pain signals and may help reset how the brain processes pain.

Beijing
NCT05864053Recruiting· Phase 1/Phase 2
Ketamine medicine trial for chronic nerve pain in adults

This Phase 1/2 study tests hydroxynorketamine (a related ketamine-type medicine) to see if it can reduce chronic nerve pain in the arms or legs. You may be able to join if you have nerve pain for more than 3 months and meet safety and health check requirements.

Chicago, Illinois
NCT07247006Not yet recruiting· Phase 2
Ketamine therapy for hard-to-treat depression

This study tests whether ketamine, given with talk therapy, can help people whose depression hasn't improved with at least two antidepressants. It aims to see if this combination can reduce depression symptoms.

Rochester, New York
NCT07063108Not yet recruiting· Phase 4
S-ketamine for older adults having non-cardiac surgery

This trial tests whether a medicine called S-ketamine (a type of anesthetic) can safely improve recovery in older adults during major surgery. Participating may help reduce pain and confusion after surgery.

NCT07009158Recruiting· Phase 1/Phase 2
Ketamine plus therapy for pain and PTSD

This trial tests if ketamine combined with talk therapy helps people with both chronic pain and PTSD. Participants receive ketamine through an IV in group therapy sessions over several weeks, with the goal of reducing pain and PTSD symptoms.

Kingston, Ontario

Hear when a new Complex Regional Pain Syndromes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.